iPS cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy
Cell types differentiated from induced pluripotent stem cells (iPSCs) are frequently arrested in their development program, more closely resembling a fetal rather than an adult phenotype, potentially limiting their utility for downstream clinical applications. The fetal phenotype of iPSC‐derived den...
主要な著者: | Horton, C, Davies, TJ, Lahiri, P, Sachamitr, P, Fairchild, PJ |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Wiley
2019
|
類似資料
-
Cross presentation of antigen by dendritic cells: mechanisms and implications for immunotherapy.
著者:: Sachamitr, P, 等
出版事項: (2012) -
Towards the rational design of a next-generation dendritic cell vaccine for cancer immunotherapy
著者:: Bravo, M, 等
出版事項: (2021) -
Directed differentiation of human induced pluripotent stem cells into dendritic cells displaying tolerogenic properties and resembling the CD141+ subset
著者:: Sachamitr, P, 等
出版事項: (2018) -
Enhancement of tolerogenic or immunostimulatory potential of dendritic cells for therapeutic goals
著者:: Hanif, Javanmard Khameneh
出版事項: (2011) -
Enhancement of tolerogenic or immunostimulatory potential of dendritic cells for therapeutic goals.
著者:: Hanif Javanmard Khameneh
出版事項: (2014)